Our observations are in agreement with results of Kim (1993), which demonstrated that the inhibitory effect of anti-VEGF antibody on tumour growth was more pronounced in the case of human A673 rhabdomyosarcoma secreting the highest quantity of VEGF and giving the most rapidly growing tumours as compared to G55 glioblastoma and SK-LMS-myosarcoma. Here, VEGFA is linked to rhabdomyosarcoma.